| Financial Year |
March 31 2023 |
| Monetary Funds |
752,085,763.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
49,294,940.91 |
| Accounts Receivable |
674,506,069.23 |
| Advances to Suppliers |
92,859,316.83 |
| Other Receivables |
5,366,509.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
367,796,001.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
54,013,874.73 |
| Total Current Assets |
1,995,922,477.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,829,058.35 |
| Investment Properties |
-- |
| Fixed Assetes |
1,131,285,763.60 |
| Under-construction Projects |
210,278,764.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,940,323.25 |
| R&D expenses |
-- |
| Goodwill |
265,971,074.73 |
| Long-Term Deferred and Prepaid Expenses |
27,569,397.47 |
| Deferred Income Tax Assets |
13,556,256.87 |
| Other Non-Current Assets |
189,220,306.17 |
| Sub-Total of Non-Current Assets |
1,941,410,504.13 |
| Total Assets |
3,937,332,981.38 |
| Short-Term Loans |
183,970,377.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
62,694,304.13 |
| Accounts Payable |
187,941,484.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,685,995.28 |
| Taxes Payable |
15,739,360.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,231,312.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
134,512,678.61 |
| Other Current Liabilities |
7,236,870.33 |
| Sub-Total of Current Liabilities |
637,347,844.59 |
| Long-term Loans |
620,422,201.25 |
| Bonds Payable |
572,334,705.33 |
| Long-Term Accounts Payable |
43,528,881.02 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,263,063.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,316,765,410.68 |
| Total Liabilities |
1,954,113,255.27 |
| Paid-In Capital(Or Share Stock) |
211,470,000.00 |
| Capital Surplus |
985,738,978.24 |
| Surplus Reserve |
33,582,617.86 |
| LESS:Treasury Stock |
21,205,200.00 |
| Undistributed Profits |
395,041,217.00 |
| Minority Stockholder's Interest |
258,879,197.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,724,340,528.28 |
| Owner's Equity（Stockholder's Equity） |
1,983,219,726.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,937,332,981.38 |
